Media Release
Sudarshan Pharma Industries Limited gets listed on BSE SME Platform
Mumbai, 22nd March 2023: Sudarshan Pharma Industries Limited became the 426th company to get listed on the BSE SME Platform on March 22, 2023 after successfully completing its public issue on March 14th.
Sudarshan Pharma Industries Limited is a Mumbai registered company, engaged in contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients' specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
For details on the issue, please visit
https://www.bseindia.com/markets/publicIssues/DisplayIPO.aspx?id=2953&type=IPO&idtype=2&status=H&IPONo=6074&startdt=09-03-2023
About BSE
BSE (formerly Bombay Stock Exchange) established in 1875, is Asia’s first & the world’s fastest Stock Exchange with a speed of 6 microseconds. BSE is India’s leading exchange group and has played a prominent role in developing the Indian capital market. BSE is a corporatized and demutualised entity, with a broad shareholder base. BSE provides an efficient and transparent market for trading in equity, debt instruments, equity derivatives, currency derivatives, interest rate derivatives, mutual funds and stock lending and borrowing.
BSE also has a dedicated platform for trading in equities of small and medium enterprises (SMEs) that has been highly successful. BSE provides a host of other services to capital market participants including risk management, clearing, settlement, market data services and education. It has a global reach with customers around the world and a nation-wide presence. BSE’s systems and processes are designed to safeguard market integrity, drive the growth of the Indian capital market, and stimulate innovation and competition across all market segments.Indian Clearing Corporation Limited, a wholly owned subsidiary of BSE, acts as the central counterparty to all trades executed on the BSE and other exchanges trading platform and provides full novation, guaranteeing the settlement of all bonafide trades executed. BSE Institute Ltd, another fully owned subsidiary of BSE runs one of the most respected capital market educational institutes in the country. Central Depository Services Ltd. (CDSL), associate company of BSE, is one of the two Depositories in India.
Media Contact:
Santanu Chakraborty / Sudhish Pillai / Rahul Vyas
022 2272 8516 / 2272 5156 / 22728472
Santanu.Chakraborty@bseindia.com / Sudhish.Pillai@bseindia.com / Rahul.vyas@indiainx.com